AgingResearch.NewsJoin free

Jiangsu Hansoh Pharmaceutical

Organisation

Trials

  • NCT07822542

    Phase 3, Not yet recruiting, 448 people, 16 Sept 2026

  • NCT07754123

    Phase 3, Not yet recruiting, 206 people, 10 Aug 2026

  • NCT07156539

    Phase 3, Not yet recruiting, 546 people, 5 Sept 2025

  • NCT07001787

    Phase 1, Not yet recruiting, 88 people, 3 Jun 2025

  • NCT06963502

    Phase 1, Not yet recruiting, 762 people, 9 May 2025

  • NCT06901648

    Phase 2, Completed, 275 people, 30 Mar 2025

  • NCT06594874

    Phase 1, Not yet recruiting, 350 people, 19 Sept 2024

  • NCT06110663

    Phase 3, Status unknown, 314 people, 1 Nov 2023

  • NCT05777109

    Phase 1, Status unknown, 180 people, 21 Mar 2023

  • NCT05504213

    Phase 1, Status unknown, 224 people, 17 Aug 2022

  • NCT05367765

    Phase 4, Not yet recruiting, 2,400 people, 10 May 2022

  • NCT04951648

    Phase 3, Status unknown, 220 people, 7 Jul 2021

  • NCT04881006

    Phase 1, Completed, 30 people, 11 May 2021

  • NCT04880993

    Phase 1, Completed, 30 people, 11 May 2021

  • NCT04762459

    Collaborator, Phase 3, Enrolling by invitation, 606 people, 21 Feb 2021

  • NCT04536558

    Collaborator, Phase 3, Status unknown, 352 people, 2 Sept 2020

  • NCT04500717

    Collaborator, Phase 3, Status unknown, 460 people, 5 Aug 2020

  • NCT04500704

    Collaborator, Phase 3, Status unknown, 166 people, 5 Aug 2020

  • NCT03849768

    Phase 3, Status unknown, 429 people, 21 Feb 2019

  • NCT02477969

    Phase 3, Status unknown, 587 people, 23 Jun 2015